F. Tas Et Al. , "Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer," BIOMEDICAL REPORTS , vol.4, no.5, pp.609-614, 2016
Tas, F. Et Al. 2016. Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer. BIOMEDICAL REPORTS , vol.4, no.5 , 609-614.
Tas, F., Bilgin, E., Tastekin, D., Erturk, K., & Duranyildiz, D., (2016). Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer. BIOMEDICAL REPORTS , vol.4, no.5, 609-614.
Tas, Faruk Et Al. "Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer," BIOMEDICAL REPORTS , vol.4, no.5, 609-614, 2016
Tas, Faruk Et Al. "Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer." BIOMEDICAL REPORTS , vol.4, no.5, pp.609-614, 2016
Tas, F. Et Al. (2016) . "Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer." BIOMEDICAL REPORTS , vol.4, no.5, pp.609-614.
@article{article, author={Faruk TAŞ Et Al. }, title={Serum IGF-1 and IGFBP-3 levels as clinical markers for patients with lung cancer}, journal={BIOMEDICAL REPORTS}, year=2016, pages={609-614} }